Details
Stereochemistry | ABSOLUTE |
Molecular Formula | C20H22O7 |
Molecular Weight | 374.3845 |
Optical Activity | UNSPECIFIED |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C(O)C=CC(C[C@@H]2COC(=O)[C@@]2(O)CC3=CC(OC)=C(O)C=C3)=C1
InChI
InChIKey=ZITBJWXLODLDRH-JLTOFOAXSA-N
InChI=1S/C20H22O7/c1-25-17-8-12(3-5-15(17)21)7-14-11-27-19(23)20(14,24)10-13-4-6-16(22)18(9-13)26-2/h3-6,8-9,14,21-22,24H,7,10-11H2,1-2H3/t14-,20-/m1/s1
Molecular Formula | C20H22O7 |
Molecular Weight | 374.3845 |
Charge | 0 |
Count |
|
Stereochemistry | ABSOLUTE |
Additional Stereochemistry | No |
Defined Stereocenters | 2 / 2 |
E/Z Centers | 0 |
Optical Activity | UNSPECIFIED |
Wikstromol is the enantiomer of nortrachelogenin, isolated from Trachelospermum asiaticum var. intermedium and Pinus palustris. Wikstromol exhibited acetylcholinesterase (AChE) inhibitory. It has been found to be active against P-388 lymphocytic leukemia growth implanted in mice. The reason for this is at present unclear, although it is possible that wikstromol is either metabolized to an active antileukemic agent by the host or else serves as a biological response modifier.
CNS Activity
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL220 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24047498 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
(+)-Nortrachelogenin, A New Pharmacologically Active Lignan From Wikstroemia indica. | 1979 Mar |
|
(+)Nortrachelogenin, a new pharmacologically active lignan from Wikstroemia indica. | 1979 Mar-Apr |
|
(+)-Nortrachelogenin, a new pharmacologically active lignan from Wikstroemia indica. | 1979 Mar-Apr |
|
Antitumor agents. 49 tricin, kaempferol-3-O-beta-D-glucopyranoside and (+)-nortrachelogenin, antileukemic principles from Wikstroemia indica. | 1981 Sep-Oct |
|
Stereoselectivity questions in the synthesis of wikstromol. | 1990 Nov-Dec |
|
Antifungal, antimitotic and anti-HIV-1 agents from the roots of Wikstroemia indica. | 2000 Aug |
|
Enantioselective synthesis of (-)-wikstromol using a new approach via malic acid. | 2001 Apr 6 |
Patents
Sample Use Guides
In Vivo Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/27805400
Mice: 60 or 100 mg/30 mg of thiopental
Route of Administration:
Unknown
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/10985087
Wikstromol demonstrated moderate activity against HIV-1 in vitro with IC(50)s ranger from 4.02 to 5.74 uM.
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 08:38:28 GMT 2023
by
admin
on
Sat Dec 16 08:38:28 GMT 2023
|
Record UNII |
5HG1T9G09U
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
5HG1T9G09U
Created by
admin on Sat Dec 16 08:38:28 GMT 2023 , Edited by admin on Sat Dec 16 08:38:28 GMT 2023
|
PRIMARY | |||
|
61521-74-2
Created by
admin on Sat Dec 16 08:38:28 GMT 2023 , Edited by admin on Sat Dec 16 08:38:28 GMT 2023
|
PRIMARY | |||
|
479756
Created by
admin on Sat Dec 16 08:38:28 GMT 2023 , Edited by admin on Sat Dec 16 08:38:28 GMT 2023
|
PRIMARY | |||
|
DTXSID70977093
Created by
admin on Sat Dec 16 08:38:28 GMT 2023 , Edited by admin on Sat Dec 16 08:38:28 GMT 2023
|
PRIMARY |